======= PSMG2 ======= == Gene Information == * **Official Symbol**: PSMG2 * **Official Name**: proteasome assembly chaperone 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56984|56984]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q969U7|Q969U7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PSMG2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PSMG2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609702|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Chaperone protein which promotes assembly of the 20S proteasome as part of a heterodimer with PSMG1. The PSMG1-PSMG2 heterodimer binds to the PSMA5 and PSMA7 proteasome subunits, promotes assembly of the proteasome alpha subunits into the heteroheptameric alpha ring and prevents alpha ring dimerization. {ECO:0000269|PubMed:16251969, ECO:0000269|PubMed:17707236}. |PAC2| |proteasome assembly| |spindle checkpoint| |mitotic spindle checkpoint| |mitotic spindle assembly checkpoint| |spindle assembly checkpoint| |negative regulation of mitotic metaphase/anaphase transition| |negative regulation of metaphase/anaphase transition of cell cycle| |negative regulation of mitotic sister chromatid separation| |negative regulation of chromosome separation| |negative regulation of mitotic sister chromatid segregation| |negative regulation of sister chromatid segregation| |negative regulation of chromosome segregation| |negative regulation of mitotic nuclear division| |negative regulation of nuclear division| |regulation of mitotic metaphase/anaphase transition| |regulation of metaphase/anaphase transition of cell cycle| |regulation of mitotic sister chromatid separation| |regulation of chromosome separation| |regulation of mitotic sister chromatid segregation| |regulation of sister chromatid segregation| |regulation of chromosome segregation| |negative regulation of chromosome organization| |mitotic cell cycle checkpoint| |regulation of mitotic nuclear division| |regulation of nuclear division| |cell cycle checkpoint| |negative regulation of mitotic cell cycle phase transition| |negative regulation of cell cycle phase transition| |negative regulation of mitotic cell cycle| |negative regulation of cell cycle process| |regulation of chromosome organization| |negative regulation of organelle organization| |regulation of mitotic cell cycle phase transition| |regulation of cell cycle phase transition| |negative regulation of cell cycle| |mitotic cell cycle process| |regulation of mitotic cell cycle| |mitotic cell cycle| |negative regulation of cellular component organization| |regulation of cell cycle process| |cellular protein-containing complex assembly| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |negative regulation of cell death| |cell cycle process| |regulation of cell cycle| |regulation of organelle organization| |cell cycle| |regulation of apoptotic process| |protein-containing complex assembly| |regulation of programmed cell death| |regulation of cell death| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp225|Celastrol 0.12μM R05 exp225]]|-1.7| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.76| |[[:results:exp302|35°C R06 exp302]]|1.77| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|1.8| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|1.83| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|1.86| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.02| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|2.02| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|2.1| |[[:results:exp447|Amiloride 100μM R08 exp447]]|2.27| ^Gene^Correlation^ |[[:human genes:p:psmg1|PSMG1]]|0.443| |[[:human genes:p:psmg4|PSMG4]]|0.431| |[[:human genes:d:dolk|DOLK]]|0.427| |[[:human genes:r:rabggtb|RABGGTB]]|0.424| |[[:human genes:d:dhrsx|DHRSX]]|0.41| |[[:human genes:p:pgm3|PGM3]]|0.402| |[[:human genes:p:ppcdc|PPCDC]]|0.4| Global Fraction of Cell Lines Where Essential: 270/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|10/28| |blood|11/28| |bone|10/26| |breast|16/33| |central nervous system|17/56| |cervix|1/4| |colorectal|10/17| |esophagus|7/13| |fibroblast|0/1| |gastric|4/16| |kidney|2/21| |liver|7/20| |lung|18/75| |lymphocyte|7/16| |ovary|11/26| |pancreas|20/24| |peripheral nervous system|2/16| |plasma cell|5/15| |prostate|0/1| |skin|7/24| |soft tissue|3/9| |thyroid|1/2| |upper aerodigestive|8/22| |urinary tract|14/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1066 * **Expression level (log2 read counts)**: 5.51 {{:chemogenomics:nalm6 dist.png?nolink |}}